CAR-T Cell Cancer Therapy to Save Lives (Media Release)

August 5, 2019
https://www.premier.vic.gov.au/car-t-cell-cancer-therapy-to-save-lives/ The Victorian and Commonwealth Governments work together to make CAR-T Cell Therapy available to patients CAR-T Cell Therapy is...
Read More

Australian Actor Tom Long cancer-free after medical trial

July 29, 2019
The Age, 28 July 2019 By Melissa Cunningham Former SeaChange actor Tom Long was on the brink of death when...
Read More

Cartherics’ research team just got bigger

July 18, 2019
As of July, the number of scientists sharing the work load in Cartherics’ laboratory hit an even dozen.  That’s thanks...
Read More

Patent office reopens major CRISPR battle between Broad Institute and Univ. of California

July 3, 2019
STAT Biotech - By Sharon Begley @sxbegle JUNE 25, 2019 The U.S. patent office has declared an interference between a dozen...
Read More

Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting …….

June 24, 2019
Cartherics shareholders Thao and Luyen Nguyen at the June 2019 Board Meeting with Cartherics Chairman Bob Moses and CEO Alan Trounson celebrating...
Read More

Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace

June 7, 2019
Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been...
Read More

Science and Technology priorities – Election 2019

May 8, 2019
MEDIA RELEASE 8 May 2019 Parties use science to set themselves apart .... The major parties have laid out their science...
Read More

The Next Frontier of CAR-T Cell Therapy: Solid Tumors

April 4, 2019
The Technology has wowed the field by all but obliterating some patients' blood cancers, but sold malignancies present new challenges...
Read More

Miracle Elixirs

April 4, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”- a...
Read More

It’s time for a worldwide moratorium on editing human embryos

April 2, 2019
by Alan Trounson Hear Alan Trounson discuss the issue Saturday 6 April at 12 noon on ABC Radio National’s The...
Read More

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

April 2, 2019
https://health.ucsd.edu/news/releases/Pages/2019-04-01-UC-San-Diego-Health-Treats-Cancer-Patient-with-Stem-Cell-Derived-Natural-Killer-Cells.aspx UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells Fate Therapeutics, in collaboration with...
Read More

Tom’s Long Fight

March 25, 2019
Tom Long's battle with Multiple Myeloma Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday...
Read More

From Bangladesh to Melbourne …… via Perth

March 25, 2019
Ms Rasa Islam is Cartherics’ first full-time PhD student. She’s joining the team under a prestigious Cooperative Research Centre (CRC)...
Read More

Australia is handicapped in the delivery of cell therapies, says Alan Trounson

March 21, 2019
THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer...
Read More

Safer cells for immunotherapy

February 13, 2019
Cartherics Pty Ltd teams up with Canada's panCELLa Inc to bring the power of safe cell therapy to a greater...
Read More

Eradicate Cancer 2020 – Next frontiers in immunotherapy

January 29, 2019
Melbourne Convention and Exhibition Centre, 25-27 March 2020 "Success Breeds Success" The field of immunotherapy against cancers is making unprecedented...
Read More

SUPER-CHARGING THE IMMUNE SYSTEM TO FIGHT CANCER

January 21, 2019
Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and...
Read More

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories

December 20, 2018
https://www.eurekalert.org/pub_releases/2018-12/uoc--nci120418.php In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells...
Read More